Companies › GUTS
FRACTYL HEALTH INC (GUTS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001572616 · EDGAR filings · Updated 2026-07-15
FRACTYL HEALTH INC (GUTS) has reported institutional ownership of 45.4%, with 83 institutional managers holding positions valued at $33.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-15 — Current report (8-K) filed
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-11 — Current report (8-K) filed
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, FRACTYL HEALTH INC has 83 institutional holders and institutional ownership of 45.4%.
Insider activity
Insiders reported 1 transactions (1 buys, 0 sells) across 1 reporting insiders, with a net reported value of $20.0K.
Data flags from SEC filings
Related companies
SEER INC (SEER) · HUMACYTE INC (HUMA) · NUVECTIS PHARMA INC (NVCT) · CHAMPIONS ONCOLOGY (CSBR) · TSCAN THERAPEUTICS INC (TCRX) · LIFEVANTAGE CORP (LFVN)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.